Generation Bio Co. (GBIO)
Feb 9, 2026 - GBIO was delisted (reason: acquired by XOMA)
5.34
-0.40 (-6.97%)
Inactive · Last trade price on Feb 6, 2026

Generation Bio Co. Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Generation Bio Co. stock had an average target of $8.88, with a low estimate of $5.00 and a high estimate of $15.

Price Target: $8.88 (+66.29%)
Analyst Consensus: Buy

Price Target

TargetLowAverageMedianHigh
Price$5.00$8.88n/a$15
Change-6.37%+66.29%n/a+180.90%

Analyst Ratings

The average analyst rating for Generation Bio Co. stock from 5 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.

Recommendation Trends

No data available
RatingOct 2026
Strong Buyn/a
Buyn/a
Holdn/a
Selln/a
Strong Selln/a
Totaln/a

Financial Forecast

Revenue This Year
11.21M
from 19.89M
Decreased by -43.64%
Revenue Next Year
n/a
from 11.21M
EPS This Year
-13.25
from -19.76
EPS Next Year
-5.99
from -13.25
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
---5.90M19.89M11.21M-
Revenue Growth
----236.92%-43.64%-
EPS
-29.54-21.17-23.51-19.63-19.76-13.25-5.99
No. Analysts
-----66

Revenue Forecast

Revenue202520262027202820292030
High12.9Mn/a
Avg11.2Mn/a
Low9.3Mn/a

Revenue Growth

Revenue Growth202520262027202820292030
High
-35.1%
-
Avg
-43.6%
-
Low
-53.2%
-

EPS Forecast

EPS202520262027
High-12.63-0.27
Avg-13.25-5.99
Low-13.66-12.09

EPS Growth

EPS Growth202520262027
High--
Avg--
Low--